Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Keun Won Ryu 6 Articles
Gastrointestinal Cancer
Development and Validation of a Symptom-Focused Quality of Life Questionnaire (KOQUSS-40) for Gastric Cancer Patients after Gastrectomy
Bang Wool Eom, Joongyub Lee, In Seob Lee, Young-Gil Son, Keun Won Ryu, Sung Geun Kim, Hyoung-Il Kim, Young-Woo Kim, Seong-Ho Kong, Oh Kyoung Kwon, Ji-Ho Park, Ji Yeong An, Chang Hyun Kim, Byoung-Jo Suh, Hong Man Yoon, Myoung Won Son, Ji Yeon Park, Jong-Min Park, Sang-Ho Jeong, Moon-Won Yoo, Geum Jong Song, Han-Kwang Yang, Yun-Suhk Suh, Ki Bum Park, Sang-Hoon Ahn, Dong Woo Shin, Ye Seob Jee, Hye-Seong Ahn, Sol Lee, Jae Seok Min, Haejin In, Ahyoung Kim, Hoon Hur, Hyuk-Joon Lee, on behalf of KOrean QUality of life in Stomach cancer patients Study group (KOQUSS)
Cancer Res Treat. 2021;53(3):763-772.   Published online December 29, 2020
DOI: https://doi.org/10.4143/crt.2020.1270
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Patients who have undergone gastrectomy have unique symptoms that are not appropriately assessed using currently available tools. This study developed and validated a symptom-focused quality of life (QoL) questionnaire for patients who have received gastrectomy for gastric cancer. Materials and Methods Based on a literature review, patient interviews, and expert consultation by the KOrean QUality of life in Stomach cancer patients Study group (KOQUSS), the initial item pool was developed. Two large-scale developmental studies were then sequentially conducted for exploratory factor analyses for content validity and item reduction. The final item pool was validated in a separate cohort of patients and assessed for internal consistency, test-retest reliability, construct validity, and clinical validity.
Results
The initial questionnaire consisted of 46-items in 12 domains. Data from 465 patients at 11 institutions, followed by 499 patients at 13 institutions, were used to conduct item reduction and exploratory factor analyses. The final questionnaire (KOQUSS-40) comprised 40 items within 11 domains. Validation of KOQUSS-40 was conducted on 413 patients from 12 hospitals. KOQUSS-40 was found to have good model fit. The mean summary score of the KOQUSS-40 was correlated with the EORTC QLQ-C30 and STO22 (correlation coefficients, 0.821 and 0.778, respectively). The KOQUSS-40 score was also correlated with clinical factors, and had acceptable internal consistency (> 0.7). Test-retest reliability was greater than 0.8. Conclusion The KOQUSS-40 can be used to assess QoL of gastric cancer patients after gastrectomy and allows for a robust comparison of surgical techniques in clinical trials.

Citations

Citations to this article as recorded by  
  • Global status of research on gastrointestinal cancer patients’ quality of life: A bibliometric and visual analysis from 2003 to 2023
    Xiaoqin Wang, Caihua Wang, Wenjin Han, Jiaru Sun, Zhaozhao Hui, Shuangyan Lei, Huili Wu, Xiaohong Liu
    Heliyon.2024; 10(1): e23377.     CrossRef
  • Development and Feasibility Assessment of Mobile Application-Based Digital Therapeutics for Postoperative Supportive Care in Gastric Cancer Patients Following Gastrectomy
    Ji-Hyeon Park, Hyuk-Joon Lee, JeeSun Kim, Yo-Seok Cho, Sunjoo Lee, Seongmin Park, Hwinyeong Choe, Eunhwa Song, Youngran Kim, Seong-Ho Kong, Do Joong Park, Byung-Ho Nam, Han-Kwang Yang
    Journal of Gastric Cancer.2024; 24(4): 420.     CrossRef
  • Effect of Four Main Gastrectomy Procedures for Proximal Gastric Cancer on Patient Quality of Life: A Nationwide Multi-Institutional Study
    Koji Nakada, Akitoshi Kimura, Kazuhiro Yoshida, Nobue Futawatari, Kazunari Misawa, Kuniaki Aridome, Yoshiyuki Fujiwara, Kazuaki Tanabe, Hirofumi Kawakubo, Atsushi Oshio, Yasuhiro Kodera
    Journal of Gastric Cancer.2023; 23(2): 275.     CrossRef
  • Quality of life after gastric cancer surgery
    Jae Kyun Park, Hyuk-Joon Lee
    Foregut Surgery.2023; 3(2): 27.     CrossRef
  • Long-term Functional and Patient-reported Outcomes Between Intra-corporeal Delta-shaped Gastroduodenostomy and Gastrojejunostomy After Laparoscopic Distal Gastrectomy
    Sin Hye Park, Hong Man Yoon, Keun Won Ryu, Young-Woo Kim, Mira Han, Bang Wool Eom
    Journal of Gastric Cancer.2023; 23(4): 561.     CrossRef
  • Potential Applicability of Local Resection With Prophylactic Left Gastric Artery Basin Dissection for Early-Stage Gastric Cancer in the Upper Third of the Stomach
    Yoshimasa Akashi, Koichi Ogawa, Katsuji Hisakura, Tsuyoshi Enomoto, Yusuke Ohara, Yohei Owada, Shinji Hashimoto, Kazuhiro Takahashi, Osamu Shimomura, Manami Doi, Yoshihiro Miyazaki, Kinji Furuya, Shoko Moue, Tatsuya Oda
    Journal of Gastric Cancer.2022; 22(3): 184.     CrossRef
  • Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
    Alison Rowsell, Samantha C. Sodergren, Vassilios Vassiliou, Anne-Sophie Darlington, Marianne G. Guren, Bilal Alkhaffaf, Chantelle Moorbey, Kristopher Dennis, Mitsumi Terada
    Gastric Cancer.2022; 25(4): 665.     CrossRef
  • Patient-reported gastrointestinal symptoms following surgery for gastric cancer and the relative risk factors
    Rui Xu, Qiong Gu, Shuomeng Xiao, Ping Zhao, Zhi Ding
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Prospective multicentre randomised clinical trial comparing survival rates, quality of life and nutritional status between advanced gastric cancer patients with different follow-up intensities: study protocol for the STOFOLUP trial
    Bang Wool Eom, Dong-Hoe Koo, Ji Yeong An, Han Hong Lee, Hyoung-Il Kim, Hoon Hur, Moon-Won Yoo, Min-Hee Ryu, Hyuk-Joon Lee, Su Mi Kim, Ji-Ho Park, Jae Seok Min, Kyung Won Seo, Sang-Ho Jeong, Oh Jeong, Oh Kyoung Kwon, Seung Wan Ryu, Chang Hak Yoo, Jae Moon
    BMJ Open.2021; 11(12): e056187.     CrossRef
  • 8,954 View
  • 334 Download
  • 8 Web of Science
  • 9 Crossref
Close layer
Genome-Wide Association of Genetic Variation in the PSCA Gene with Gastric Cancer Susceptibility in a Korean Population
Boyoung Park, Sarah Yang, Jeonghee Lee, Hae Dong Woo, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Young-Il Kim, Jeongseon Kim
Cancer Res Treat. 2019;51(2):748-757.   Published online September 5, 2018
DOI: https://doi.org/10.4143/crt.2018.162
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Half of the world’s gastric cancer cases and the highest gastric cancer mortality rates are observed in Eastern Asia. Although several genome-wide association studies (GWASs) have revealed susceptibility genes associated with gastric cancer, no GWASs have been conducted in the Korean population, which has the highest incidence of gastric cancer.
Materials and Methods
We performed genome scanning of 450 gastric cancer cases and 1,134 controls via Affymetrix Axiom Exome 319 arrays, followed by replication of 803 gastric cancer cases and 3,693 healthy controls.
Results
We showed that the rs2976394 in the prostate stem cell antigen (PSCA) gene is a gastriccancer-susceptibility gene in a Korean population, with genome-wide significance and an odds ratio (OR) of 0.70 (95% confidence interval [CI], 0.64 to 0.77). A strong linkage disequilibrium with rs2294008 was also found, indicating an association with susceptibility. Individuals with the CC genotype of the PSCA gene showed an approximately 2-fold lower risk of gastric cancer compared to those with the TT genotype (OR, 0.47; 95% CI, 0.39 to 0.57). The effect of the PSCA gene on gastric cancer was more prominent in the female population and for diffuse type gastric cancer.
Conclusion
Our result confirmed that the PSCA gene may be the most important susceptibility gene for gastric cancer risk in a Korean population.

Citations

Citations to this article as recorded by  
  • Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population
    Hyojin Pyun, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
    Cancer Research and Treatment.2024; 56(1): 191.     CrossRef
  • HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
    Ansley Gnanapragasam, Eftyhios Kirbizakis, Anna Li, Kyle H. White, Katelyn L. Mortenson, Juliana Cavalcante de Moura, Wajih Jawhar, Yifei Yan, Reilly Falter, Colleen Russett, Betty Giannias, Sophie Camilleri-Broët, Nicholas Bertos, Jonathan Cools-Lartigue
    Cancer Research.2024; 84(14): 2377.     CrossRef
  • High Polygenic Risk Scores Positively Associated with Gastric Cancer Risk Interact with Coffee and Polyphenol Intake and Smoking Status in Korean Adults
    Meiling Liu, Sang-Shin Song, Sunmin Park
    Nutrients.2024; 16(19): 3263.     CrossRef
  • Interaction between dietary potassium intake and TNF-α rs1800629 genetic polymorphism in gastric cancer risk: a case–control study conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    British Journal of Nutrition.2023; 130(5): 887.     CrossRef
  • Rare variants confer shared susceptibility to gastrointestinal tract cancer risk
    Ji Zheng, Xin Wang, Jingrao Li, Yuanna Wu, Jiang Chang, Junyi Xin, Meilin Wang, Tianpei Wang, Qingyi Wei, Mengyun Wang, Ruoxin Zhang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The association of dietary fibre intake and the IL13 rs20541 polymorphism with the risk of gastric cancer: a case-control study in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Clinical Nutrition.2022; 76(7): 1031.     CrossRef
  • Systematic review of gastric cancer-associated genetic variants, gene-based meta-analysis, and gene-level functional analysis to identify candidate genes for drug development
    Sangjun Lee, Han-Kwang Yang, Hyuk-Joon Lee, Do Joong Park, Seong-Ho Kong, Sue K. Park
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Incidence of Hereditary Gastric Cancer May Be Much Higher than Reported
    Paula Baraúna de Assumpção, Paulo Pimentel de Assumpção, Fabiano Cordeiro Moreira, Ândrea Ribeiro-dos-Santos, Amanda F. Vidal, Leandro Magalhães, André Salim Khayat, André Maurício Ribeiro-dos-Santos, Giovanna C. Cavalcante, Adenilson Leão Pereira, Inácio
    Cancers.2022; 14(24): 6125.     CrossRef
  • Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility
    Rachel Martini, Endale Gebregzabher, Lisa Newman, Melissa B. Davis
    Cancer Discovery.2022; 12(6): 1428.     CrossRef
  • Identification of Novel Susceptible Genes of Gastric Cancer Based on Integrated Omics Data
    Huang Yaoxing, Yu Danchun, Sun Xiaojuan, Jiang Shuman, Yan Qingqing, Jia Lin
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • The Associations of Dietary Iron Intake and the Transferrin Receptor (TFRC) rs9846149 Polymorphism with the Risk of Gastric Cancer: A Case–Control Study Conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Nutrients.2021; 13(8): 2600.     CrossRef
  • Integration of GWAS and eQTL Analysis to Identify Risk Loci and Susceptibility Genes for Gastric Cancer
    Jing Ni, Bin Deng, Meng Zhu, Yuzhuo Wang, Caiwang Yan, Tianpei Wang, Yaqian Liu, Gang Li, Yanbing Ding, Guangfu Jin
    Frontiers in Genetics.2020;[Epub]     CrossRef
  • Evolutionary History of the Risk of SNPs for Diffuse-Type Gastric Cancer in the Japanese Population
    Risa L. Iwasaki, Koji Ishiya, Hideaki Kanzawa-Kiriyama, Yosuke Kawai, Jun Gojobori, Yoko Satta
    Genes.2020; 11(7): 775.     CrossRef
  • TNF genetic polymorphism (rs1799964) may modify the effect of the dietary inflammatory index on gastric cancer in a case–control study
    Jeeeun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
    Scientific Reports.2020;[Epub]     CrossRef
  • Prediction of gastric cancer risk: association between ZBTB20 genetic variance and gastric cancer risk in Chinese Han population
    Fei Bai, Ke Xiao
    Bioscience Reports.2020;[Epub]     CrossRef
  • Incidence of Stomach and Esophageal Cancers in Mongolia: Data from 2009 to 2018
    Tsegmed Sambuu, Nasanjargal Tumurbat, Bayar Davaa, Bolor-Erdene Tudev
    Euroasian Journal of Hepato-Gastroenterology.2020; 10(1): 16.     CrossRef
  • 10,109 View
  • 207 Download
  • 16 Web of Science
  • 16 Crossref
Close layer
Effects of Soy Product Intake and Interleukin Genetic Polymorphisms on Early Gastric Cancer Risk in Korea: A Case-Control Study
Sarah Yang, Yoon Park, Jeonghee Lee, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Joohon Sung, Jeongseon Kim
Cancer Res Treat. 2017;49(4):1044-1056.   Published online January 19, 2017
DOI: https://doi.org/10.4143/crt.2016.515
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The current study investigated whether the combined effects of soy intake and genetic polymorphisms of interleukin (IL) genes modify gastric cancer risk.
Materials and Methods
A total of 377 cases and 754 controls of Korean origin were included in the analysis. Soy consumption was assessed using a semi-quantitative food frequency questionnaire. Seven variants of IL10 (rs1800871), IL2 (rs2069763 and rs2069762), IL13 (rs6596090 and rs20541), and IL4R(rs7205663 and rs1805010) were genetically analyzed. To analyze the combined effect of soy intake and genetic polymorphisms, a low-intake group and high-intake group of each type of soy were categorized based on the intake level of the control group. Interactions between soy products and these genetic variants were analyzed by a likelihood ratio test, in which a multiplicative interaction term was added to the logistic regression model.
Results
A higher intake of nonfermented soy products was associated with a reduced cancer risk (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.43 to 0.90), and the reduced risk was only apparent in males (OR, 0.44; 95% CI, 0.27 to 0.71). None of the IL genetic polymorphisms examined were independently associated with gastric cancer risk. Individuals with a minor allele of IL2 rs2069762 and a higher intake of nonfermented soy food had a decreased risk of gastric cancer (OR, 0.46; 95% CI, 0.31 to 0.68) compared to those with a lower intake (pinteraction=0.039).
Conclusion
Based on the genetic characteristics of the studied individuals, the interaction between IL2 rs2069762 and nonfermented soy intake may modify the risk of gastric cancer.

Citations

Citations to this article as recorded by  
  • Polyphenol intake and gastric cancer: A case-control study in the Brazilian Amazon region
    Marcela de Araújo Fagundes, Renata Alves Carnauba, Gisele Aparecida Fernandes, Paulo Pimentel de Assumpção, Maria Paula Curado
    Cancer Epidemiology.2024; 88: 102518.     CrossRef
  • Oral Microbiota as a Diagnostic Biomarker of Digestive Cancer: A Systematic Review
    SK Aziz Ikbal, Surendra Kumar Yadav, Roopanshi Mehrotra, Tasneem Fatima, Anjusha Sharda, Srashti Gupta
    The Journal of Contemporary Dental Practice.2024; 24(11): 902.     CrossRef
  • The pertinence of gastric cancer and interleukin 10–819 single nucleotide polymorphisms: a meta-analysis and systematic review
    Qianqian Mao, Yanwen Liu, Xi Chen, Cheng Jiang Liu
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Soy Product Consumption and the Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
    Chenting Wang, Keqing Ding, Xuanzhen Xie, Jinyue Zhou, Pengju Liu, Shuang Wang, Ting Fang, Guozhang Xu, Chunlan Tang, Hang Hong
    Nutrients.2024; 16(7): 986.     CrossRef
  • Interaction between dietary potassium intake and TNF-α rs1800629 genetic polymorphism in gastric cancer risk: a case–control study conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    British Journal of Nutrition.2023; 130(5): 887.     CrossRef
  • Association between soy products, fruits, vegetables, and dairy products and gastric cancer risk in Helicobacter pylori-infected subjects: a case-control study in Korea
    Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
    Nutrition Research and Practice.2023; 17(1): 122.     CrossRef
  • Dietary intake and cancer incidence in Korean adults: a systematic review and meta-analysis of observational studies
    Ji Hyun Kim, Shinyoung Jun, Jeongseon Kim
    Epidemiology and Health.2023; : e2023102.     CrossRef
  • The association of dietary fibre intake and the IL13 rs20541 polymorphism with the risk of gastric cancer: a case-control study in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Clinical Nutrition.2022; 76(7): 1031.     CrossRef
  • Dietary Polyphenol Intake and Gastric Cancer: A Systematic Review and Meta-Analysis
    Marcela de Araújo Fagundes, Alex Richard Costa Silva, Gisele Aparecida Fernandes, Maria Paula Curado
    Cancers.2022; 14(23): 5878.     CrossRef
  • Sex-dependent associations between MAP3K1 gene polymorphisms and soy products with the gastric cancer risk in Korea: a case-control study
    Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Dietary patterns and gastric cancer risk in a Korean population: a case–control study
    Ji Hyun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Nutrition.2021; 60(1): 389.     CrossRef
  • Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer
    Xujun Song, Benno Traub, Jingwei Shi, Marko Kornmann
    International Journal of Molecular Sciences.2021; 22(2): 727.     CrossRef
  • The association between soy‐based food and soy isoflavone intake and the risk of gastric cancer: a systematic review and meta‐analysis
    Yameng Wang, Jiaping Guo, Fei Yu, Yongmei Tian, Yongjun Wu, Lingling Cui, Li‐e Liu
    Journal of the Science of Food and Agriculture.2021; 101(13): 5314.     CrossRef
  • The Associations of Dietary Iron Intake and the Transferrin Receptor (TFRC) rs9846149 Polymorphism with the Risk of Gastric Cancer: A Case–Control Study Conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Nutrients.2021; 13(8): 2600.     CrossRef
  • Identification of Dietary Pattern Networks Associated with Gastric Cancer Using Gaussian Graphical Models: A Case-Control Study
    Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Cancers.2020; 12(4): 1044.     CrossRef
  • Genome‐wide profiling of normal gastric mucosa identifies Helicobacter pylori‐ and cancer‐associated DNA methylome changes
    Hae Dong Woo, Nora Fernandez‐Jimenez, Akram Ghantous, Davide Degli Esposti, Cyrille Cuenin, Vincent Cahais, Il Ju Choi, Young‐Il Kim, Jeongseon Kim, Zdenko Herceg
    International Journal of Cancer.2018; 143(3): 597.     CrossRef
  • The association between dietary isoflavones intake and gastric cancer risk: a meta-analysis of epidemiological studies
    Jie You, Yafei Sun, Yacong Bo, Yiwei Zhu, Dandan Duan, Han Cui, Quanjun Lu
    BMC Public Health.2018;[Epub]     CrossRef
  • 9,648 View
  • 280 Download
  • 17 Web of Science
  • 17 Crossref
Close layer
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer
Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Myeong-Cherl Kook, Keun Won Ryu, Young-Woo Kim, Il Ju Choi
Cancer Res Treat. 2016;48(3):1020-1029.   Published online November 17, 2015
DOI: https://doi.org/10.4143/crt.2015.264
AbstractAbstract PDFPubReaderePub
Purpose
Negative Helicobacter pylori status has been identified as a poor prognostic factor for survival in gastric cancer (GC) patients who underwent surgery. The aim of this study was to examine the effect of H. pylori eradication on long-term outcomes after distal gastrectomy for GC.
Materials and Methods
We analyzed the survival of 169 distal GC patients enrolled in a prospective randomized trial evaluating histologic changes of gastric mucosa after H. pylori eradication in the remnant stomach. The outcomes measured were overall survival (OS) and GC recurrence rates.
Results
The median follow-up duration was 9.4 years. In the modified intention-to-treat analysis including patients who underwent H. pylori treatment (n=87) or placebo (n=82), 5-year OS rates were 98.9% in the treatment group and 91.5% in the placebo group, and KaplanMeier analysis showed no significant difference in OS (p=0.957) between groups. In multivariate analysis, no difference in overall mortality was observed between groups (adjusted hazard ratio [aHR] for H. pylori treatment, 0.75; p=0.495) or H. pylori-eradicated status (aHR for positive H. pylori status, 1.16; p=0.715), while old age, male sex, and advanced stage ≥ IIIa were independent risk factors. Six patients in the treatment group (6.9%) and seven patients in the placebo group (8.5%) had GC recurrences, and GC recurrence rates were not different according to H. pylori treatment (5-year GC recurrence rates, 4.6% in the treatment group vs. 8.5% in the placebo group; p=0.652).
Conclusion
H. pylori eradication for GC patients who underwent distal gastrectomy did not compromise long-term survival after surgery.

Citations

Citations to this article as recorded by  
  • Anti–Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy
    Zhoukai Zhao, Ruopeng Zhang, Guoming Chen, Man Nie, Feiyang Zhang, Xiaojiang Chen, Jun Lin, Zewei Chen, Feizhi Lin, Chengzhi Wei, Ziqi Zheng, Shenghang Ruan, Bowen Huang, Yingbo Chen, Runcong Nie
    JAMA Network Open.2024; 7(3): e243812.     CrossRef
  • Helicobacter Pylori and Celiac Disease Antibody Positivity Have a Higher Prevalence in Patients With Distal Gastrectomy: A Cross-Sectional Retrospective Study
    Kubilay Issever, Ersin Kuloglu, Demet Sengul, Ali Muhtaroglu, Ahmet Cumhur Dulger
    Cureus.2023;[Epub]     CrossRef
  • The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single‐center prospective study
    Senichiro Yanagawa, Nobuaki Fujikuni, Kazuaki Tanabe, Masahiro Nakahara, Toshio Noriyuki
    Cancer Reports.2023;[Epub]     CrossRef
  • Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis
    Zhifang Jia, Min Zheng, Jing Jiang, Donghui Cao, Yanhua Wu, Yuzheng Zhang, Yingli Fu, Xueyuan Cao
    BMC Cancer.2022;[Epub]     CrossRef
  • Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi
    Journal of Gastroenterology.2022; 57(7): 464.     CrossRef
  • Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
    Young-Il Kim, Il Ju Choi
    Journal of Gastric Cancer.2022; 22(3): 169.     CrossRef
  • Helicobacter Pylori and Gastric Cancer Progression
    Marina A. Senchukova
    Current Microbiology.2022;[Epub]     CrossRef
  • Identifying Factors Affecting Cancer-related Death in Patients with Adenocarcinoma Gastric Cancer; An Analysis in the Presence of Competing Risks
    Malihe Safari, Hossein Mahjub, Habib Esmaeili, Mohamad Abasi, Ghodratollah Roshanaei
    International Journal of Cancer Management.2021;[Epub]     CrossRef
  • T stage and venous invasion are crucial prognostic factors for long-term survival of patients with remnant gastric cancer: a cohort study
    Kentaro Matsuo, Sang-Woong Lee, Ryo Tanaka, Yoshiro Imai, Kotaro Honda, Kohei Taniguchi, Hideki Tomiyama, Kazuhisa Uchiyama
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Tracking the Virulent Helicobacter pylori Strains Instead of Its Pan-Screening to Prevent Gastric Cancer
    Farid Rahimi, Amin Talebi Bezmin Abadi
    BioNanoScience.2020; 10(1): 315.     CrossRef
  • Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis
    Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang
    Microbial Pathogenesis.2020; 142: 104075.     CrossRef
  • Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years
    Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sang-Hoon Ahn, Do Joong Park, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim
    Gastric Cancer.2020; 23(6): 1051.     CrossRef
  • Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study
    Hyun Ju Kim, Yun Jin Kim, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
    Gastrointestinal Endoscopy.2020; 92(3): 613.     CrossRef
  • Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy
    Youn I Choi, Jun-Won Chung
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(3): 204.     CrossRef
  • Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP)
    Minoosh Moghimi, Yousef Mortazavi, Saeed Razavi-Dizaji, Shahrbanoo Keyhanian, Zahra Ghadimi, Sahar Baba Ali, Saeideh Mazloomzadeh, Sattar Jafari, Reza Mansouri, Masoud Asadi-Khiavi
    Journal of Advances in Medical and Biomedical Research.2019; 27(124): 1.     CrossRef
  • Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
    Il Ju Choi, Myeong-Cherl Kook, Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Byung-Ho Nam
    New England Journal of Medicine.2018; 378(12): 1085.     CrossRef
  • Helicobacter pyloriEradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
    Bum Jun Kim, Hyeong Su Kim, Hyun Joo Jang, Jung Han Kim
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • Do We Need to Retest of Helicobacter pylori Infection after Gastric Cancer Surgery?
    Sang Kil Lee
    Gut and Liver.2017; 11(2): 169.     CrossRef
  • 11,977 View
  • 198 Download
  • 18 Web of Science
  • 18 Crossref
Close layer
Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study
Young-Il Kim, So Young Kim, Ji Hyun Kim, Jun Ho Lee, Young-Woo Kim, Keun Won Ryu, Jong-Hyock Park, Il Ju Choi
Cancer Res Treat. 2016;48(2):798-805.   Published online July 14, 2015
DOI: https://doi.org/10.4143/crt.2015.117
AbstractAbstract PDFPubReaderePub
Purpose
The aim of this study was to investigate whether aspirin use can reduce the incidence of gastric cancer in patients with hypertension or type 2 diabetes. Materials and Methods A total of 200,000 patients with hypertension or type 2 diabetes were randomly selected from the Korean National Health Insurance claim database. Of these, 3,907 patients who used 100 mg of aspirin regularly (regular aspirin users) and 7,808 patients who did not use aspirin regularly (aspirin non-users) were selected at a frequency of 1:2, matched by age, sex, comorbid illnesses (type 2 diabetes and hypertension), and observation periods. The incidence of gastric cancer in this cohort was then assessed during the observation period of 2004 to 2010.
Results
In the matched cohort, the incidence rates of gastric cancer were 0.8% (31/3,907) for regular aspirin users and 1.1% (86/7,808) for aspirin non-users, but the cumulative incidence rates were not significantly different between groups (p=0.116, log-rank test). However, in multivariate analysis, regular aspirin users had a reduced risk of gastric cancer (adjusted hazard ratio [aHR], 0.71; 95% confidential interval [CI], 0.47 to 1.08; p=0.107). Duration of aspirin use showed significant association with reduction of gastric cancer risk (aHR for each year of aspirin use, 0.85; 95% CI, 0.73 to 0.99; p=0.044), particularly in patients who used aspirin for more than 3 years (aHR, 0.40; 95% CI, 0.16 to 0.98; p=0.045). Conclusion Long-term low-dose aspirin use was associated with reduced gastric cancer risk in patients with hypertension or type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses
    Xiao Bai, Si-Qi Ding, Xue-Ping Zhang, Ming-Hao Han, Dong-Qiu Dai
    Cancers.2023; 15(2): 372.     CrossRef
  • In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells
    Monica Susan, Ioana Macasoi, Iulia Pinzaru, Cristina Dehelean, Iosif Ilia, Razvan Susan, Ioana Ionita
    Current Oncology.2023; 30(7): 6197.     CrossRef
  • Prediction algorithm for gastric cancer in a general population: A validation study
    Martin C. S. Wong, Eman Yee‐man Leung, Sarah T. Y. Yau, Sze Chai Chan, Shaohua Xie, Wanghong Xu, Junjie Huang
    Cancer Medicine.2023; 12(21): 20544.     CrossRef
  • Evaluation of clopidogrel use on gastric precancerous lesions: Does it have chemopreventive effect?
    Taner AKYOL
    Journal of Medicine and Palliative Care.2023; 4(5): 524.     CrossRef
  • Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study
    Jessica J P Shami, Jiaxi Zhao, Swathi Pathadka, Eric Yuk Fai Wan, Joseph Edgar Blais, Pareen Vora, Montse Soriano-Gabarró, Ka Shing Cheung, W K Leung, Ian C K Wong, Esther W Chan
    BMJ Open.2022; 12(2): e050510.     CrossRef
  • Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study
    Sohee Kwon, Wenjie Ma, David A. Drew, Samuel J. Klempner, Brianna M. Leonardo, Jacqueline J. Flynn, Yin Cao, Edward L. Giovannucci, Ying Bao, Charles S. Fuchs, Mingyang Song, Andrew T. Chan
    Cancer Prevention Research.2022; 15(4): 265.     CrossRef
  • Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study
    Mi Hee Cho, Tae Gon Yoo, Su-Min Jeong, Dong Wook Shin
    Cancer Prevention Research.2021; 14(1): 95.     CrossRef
  • Antibreast Cancer Activity of Aspirin-Conjugated Chalcone Polymeric Micelles
    Do Young Lee, Kang Pa Lee, Suji Beak, Ji Su Park, Young Jin Kim, Kil-Nam Kim, Song-Rae Kim, Myeong Sik Yoon
    Macromolecular Research.2021; 29(1): 105.     CrossRef
  • Effect of frequently prescribed drugs on gastric cancer risk
    Theresa Weltermann, Christian Schulz, Lukas Macke
    Best Practice & Research Clinical Gastroenterology.2021; : 101741.     CrossRef
  • Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials
    Lijuan Wang, Rongqi Zhang, Lili Yu, Jiarui Xiao, Xuan Zhou, Xinxuan Li, Peige Song, Xue Li
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
    Chin-Hsiao Tseng
    Biomolecules.2021; 11(7): 1022.     CrossRef
  • Effect of aspirin use on gastric cancer incidence and survival: A systematic review and meta‐analysis
    Ryota Niikura, Yoshihiro Hirata, Yoku Hayakawa, Takuya Kawahara, Atsuo Yamada, Kazuhiko Koike
    JGH Open.2020; 4(2): 117.     CrossRef
  • Positive association between dietary inflammatory index and gastric cancer risk: A systematic review and meta-analysis
    Ying Liang, Haoyan Jiao, Lingbo Qu, Hao Liu
    Nutrition and Cancer.2020; 72(8): 1290.     CrossRef
  • Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea
    Minji Jung, Sukhyang Lee
    Drugs & Aging.2020; 37(1): 43.     CrossRef
  • Safety of Proton Pump Inhibitors Questioned Based on a Large Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
    Johanna Simin, Qing Liu, Romina Fornes, Nele Brusselaers
    Gastroenterology.2020; 158(4): 1172.     CrossRef
  • De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study
    Soongu Kwak, You-Jung Choi, Soonil Kwon, Seo-Young Lee, Seokhun Yang, Inki Moon, Hyun-Jung Lee, Heesun Lee, Jun-Bean Park, Kyungdo Han, Yong-Jin Kim, Hyung-Kwan Kim
    International Journal of Cardiology.2020; 313: 25.     CrossRef
  • Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Peipei Liu, Úna C. McMenamin, Brian T. Johnston, Peter Murchie, Lisa Iversen, Amanda J. Lee, Pauline A. J. Vissers, Chris R. Cardwell
    British Journal of Cancer.2020; 123(2): 307.     CrossRef
  • Low‐dose aspirin and risk of gastric and oesophageal cancer: A population‐based study in the United Kingdom using The Health Improvement Network
    Luis A. García Rodríguez, Montse Soriano‐Gabarró, Pareen Vora, Lucía Cea Soriano
    International Journal of Cancer.2020; 147(9): 2394.     CrossRef
  • Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin
    Jiro Watari, Toshihiko Tomita, Katsuyuki Tozawa, Tadayuki Oshima, Hirokazu Fukui, Hiroto Miwa
    Gut and Liver.2020; 14(3): 281.     CrossRef
  • Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines
    Dominique Fausto de Souza, Thupten Tsering, Miguel N. Burnier , Vasco Bravo-Filho, Ana Beatriz Toledo Dias, Mohamed Abdouh, Alicia Goyeneche, Julia Valdemarin Burnier
    Ocular Oncology and Pathology.2020; 6(6): 442.     CrossRef
  • Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
    Yan Qiao, Tingting Yang, Yong Gan, Wenzhen Li, Chao Wang, Yanhong Gong, Zuxun Lu
    BMC Cancer.2018;[Epub]     CrossRef
  • Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer
    Min-hyung Kim, Jooyoung Chang, Warrick Junsuk Kim, Samprit Banerjee, Sang Min Park
    American Journal of Gastroenterology.2018; 113(6): 845.     CrossRef
  • Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis
    Yu-Shan Lin, Chih-Ching Yeh, Shiang-Fu Huang, Yi-Sheng Chou, Li-Tang Kuo, Fung-Chang Sung, Chih-Hsin Muo, Chien-Tien Su, Fu-Hsiung Su, Mohammad R. Akbari
    PLOS ONE.2018; 13(8): e0199014.     CrossRef
  • Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer
    Min-hyung Kim, Jooyoung Chang, Warrick Junsuk Kim, Samprit Banerjee, Sang Min Park
    American Journal of Gastroenterology.2018; 113(6): 845.     CrossRef
  • Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
    Kee Don Choi
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(4): 169.     CrossRef
  • Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer
    Yuki Michigami, Jiro Watari, Chiyomi Ito, Ken Hara, Takahisa Yamasaki, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Takeshi Morimoto, Kiron M. Das, Hiroto Miwa
    Scientific Reports.2017;[Epub]     CrossRef
  • Aspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT
    Jiang-Hua Ding, Li-Ya Yuan, Guo-An Chen
    Oncology Letters.2017; 13(2): 647.     CrossRef
  • Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis
    Xuan-zhang Huang, You Chen, Jian Wu, Xi Zhang, Cong-cong Wu, Chao-ying Zhang, Shuang-shuang Sun, Wen-jun Chen
    Oncotarget.2017; 8(3): 4781.     CrossRef
  • Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer
    Jing Zhang, Shu-Qi Li, Zhi-Hua Liao, Yu-Huan Jiang, Qing-Gen Chen, Bo Huang, Jing Liu, Yan-Mei Xu, Jin Lin, Hou-Qun Ying, Xiao-Zhong Wang
    Oncotarget.2017; 8(43): 75195.     CrossRef
  • Dietary inflammatory index and the risk of gastric cancer in a Korean population
    Sunghee Lee, Jeonghee Lee, Il Ju Choi, Young-Woo Kim, Keun Won Ryu, Young-Il Kim, Jin-Kyoung Oh, Binh Thang Tran, Jeongseon Kim
    Oncotarget.2017; 8(49): 85452.     CrossRef
  • 12,934 View
  • 182 Download
  • 35 Web of Science
  • 30 Crossref
Close layer
Characteristics of Synchronous Cancers in Gastric Cancer Patients
Ja Seong Bae, Jun Ho Lee, Keun Won Ryu, Young Woo Kim, Jae Moon Bae
Cancer Res Treat. 2006;38(1):25-29.   Published online February 28, 2006
DOI: https://doi.org/10.4143/crt.2006.38.1.25
AbstractAbstract PDFPubReaderePub
Purpose

The primary objective of the current study was to investigate the characteristics of synchronous cancers in gastric cancer patients.

Materials and Methods

We analyzed the 2,237 patients who were diagnosed between December 2000 and December 2003 with gastric cancer and synchronous cancers of organs other than the stomach.

Results

73 (3.3%) of a total of 2,237 gastric cancer patients had synchronous primary cancers. Among these 73 patients, 71 had one synchronous cancer, and two patients had double synchronous cancers. Colorectal cancer (26 patients, 34.7%) was the most frequently encountered synchronous cancer, followed by cancer of the lung (16 patients, 21.3%), esophagus (13 patients, 17.2%), and liver (8 patients, 10.7%). Synchronous cancers were detected with increased frequency in the elderly, in the patients with multiple gastric cancers, in the patients with differentiated gastric cancer, and in the patients with early gastric cancer, as determined on univariate analysis, but the differentiation of gastric cancers was the only risk factor for synchronous cancers on the multivariate analysis.

Conclusions

The differentiation of gastric cancer cells may be a risk factor for synchronous cancers in gastric cancer patients. Careful surveillance by the physician for synchronous cancer is warranted for the patients suffering from gastric cancer.

Citations

Citations to this article as recorded by  
  • Synchronous Triple Malignancy of Esophagus, Pancreas, and Pyriform Sinus: A Prima Facie Report
    Sekhar Saha, Varun Goel, Arnab Chakraborty, Vineet Talwar
    Indian Journal of Surgical Oncology.2024; 15(S2): 349.     CrossRef
  • Synchronous Gastric and Colonic Adenocarcinoma: A Case Report With its Molecular Implications
    Lakshmipriya V, Sarah Grace Priyadarshini , Neha Agarwal, Padmapriya B S
    Cureus.2024;[Epub]     CrossRef
  • Triple metachronous primary cancer of uterus, colon, and breast cancer
    Guanqiao Li, Jia Yao, Tangna Wu, Yaxiong Chen, Zhenping Wang, Yiming Wang, Fen Wang, Rui Zhong, Shiping Yang
    Medicine.2020; 99(34): e21764.     CrossRef
  • Gastric cancer and intrahepatic cholangiocarcinoma
    Alex Emmanuel Elobu, Ashok Thorat, Vianney Kweyamba, Rakesh Rai
    Formosan Journal of Surgery.2019; 52(3): 107.     CrossRef
  • Clinicopathologic characteristics and survival rate in patients with synchronous or metachronous double primary colorectal and gastric cancer
    Ji-Hyeon Park, Jeong-Heum Baek, Jun-Young Yang, Won-Suk Lee, Woon-Kee Lee
    Korean Journal of Clinical Oncology.2018; 14(2): 83.     CrossRef
  • Can positron emission tomography detect colorectal adenomas and cancers?
    Kimihiro Igarashi, Kinichi Hotta, Kenichiro Imai, Yuichiro Yamaguchi, Sayo Ito, Noboru Kawata, Masaki Tanaka, Naomi Kakushima, Kohei Takizawa, Hiroyuki Matsubayashi, Masahiro Endo, Kouiku Asakura, Takuma Oishi, Tadakazu Shimoda, Hiroyuki Ono
    Journal of Gastroenterology and Hepatology.2017; 32(3): 602.     CrossRef
  • Triple synchronous primary malignancies: a rare occurrence
    Heather Katz, Hassaan Jafri, Linda Brown, Toni Pacioles
    BMJ Case Reports.2017; : bcr-2017-219237.     CrossRef
  • A Concurrence of Adenocarcinoma with Micropapillary Features and Composite Glandular-Endocrine Cell Carcinoma in the Stomach
    Ji-Hoon Kim, Dae-Woon Eom, Cheon-Soo Park, Jae-Young Kwak, Eun-Hwa Park, Jin-Ho Kwak, Hyuk-Jae Jang, Kun-Moo Choi, Myung-Sik Han
    Journal of Gastric Cancer.2016; 16(4): 266.     CrossRef
  • Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid
    Sung Jin Oh, Dong Sik Bae, Byoung Jo Suh
    Annals of Surgical Treatment and Research.2015; 88(6): 345.     CrossRef
  • Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer
    I. Cho, J.Y. An, I.G. Kwon, Y.Y. Choi, J.H. Cheong, W.J. Hyung, S.H. Noh
    European Journal of Surgical Oncology (EJSO).2014; 40(3): 338.     CrossRef
  • Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience
    Jieun Kim, Su Mi Kim, Jeong Eun Seo, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Jae Moon Bae, Seong Il Seo
    Journal of Gastric Cancer.2014; 14(3): 211.     CrossRef
  • Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience
    Jieun Kim, Su Mi Kim, Jeong Eun Seo, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Jae Moon Bae, Seong Il Seo
    Journal of Gastric Cancer.2014; 14(3): 211.     CrossRef
  • Management of gastric epithelial neoplasia in patients requiring esophagectomy for esophageal cancer
    H. I., G. H. Kim, D. Y. Park, Y. D. Kim, B. E. Lee, D. Y. Ryu, D. U. Kim, G. A. Song
    Diseases of the Esophagus.2013; 26(6): 603.     CrossRef
  • Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report
    Takashi Sato, Koji Tomaru, Tomoko Koide, Makoto Masuda, Masaki Yamamoto, Naoki Miyazawa, Yoshiaki Inayama, Takeshi Kaneko, Yoshiaki Ishigatsubo
    Journal of Medical Case Reports.2012;[Epub]     CrossRef
  • Synchronous primary gastric cancer and renal cell carcinoma: A case report and literatures review
    Kung-Ning Hu, Wei-Hong Lai, Po-Tsang Tseng, Wen-Ching Wang, Kun-Hung Shen
    Urological Science.2012; 23(1): 28.     CrossRef
  • Synchronous multifocal early gastric cancers and rectal adenocarcinoma: Lesson learnt from image‐enhanced endoscopy
    Boon Eu Andrew KWEK, Tiing Leong ANG, Kwong Ming FOCK, Eng Kiong TEO
    Journal of Digestive Diseases.2011; 12(3): 226.     CrossRef
  • Clinical improvement of membranous nephropathy after endoscopic resection of double early gastrointestinal cancers
    Satoshi Matsui, Hiroko Tsuji, Yukinobu Takimoto, Shinji Ono
    Clinical and Experimental Nephrology.2011; 15(2): 285.     CrossRef
  • Microsatellite Instability Is Associated with the Clinicopathologic Features of Gastric Cancer in Sporadic Gastric Cancer Patients
    Shin Hyuk Kim, Byung Kyu Ahn, Young Su Nam, Joo Youn Pyo, Young Ha Oh, Kang Hong Lee
    Journal of Gastric Cancer.2010; 10(4): 149.     CrossRef
  • Second primary cancers in patients with gastric cancer
    Oktay Buyukasik, Ahmet Hasdemir, Yusuf Gulnerman, Cavit Col, Ozgur Ikiz
    Radiology and Oncology.2010;[Epub]     CrossRef
  • 9,904 View
  • 58 Download
  • 19 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP